https://ogma.newcastle.edu.au/vital/access/ /manager/Index en-au 5 New analytical techniques for determining pharmacokinetics of drugs in neonates https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:36488 Wed 20 May 2020 15:48:40 AEST ]]> Using continuing professional development with portfolio in a pharmaceutics course https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:28306 70%, five students scored between 57%–69%, one student obtained a mark of 50% and one student failed. The end of course survey revealed that while students found portfolio development challenging (40%), they also reported that it was effective for self-learning (54%). Differentiating between the concepts “reflection” and “evaluation” in CPD was problematic for some students and the use of clearer, simpler language should be used to explain these processes in future CPD work.]]> Wed 11 Apr 2018 17:05:02 AEST ]]> Female reproductive tract pain: targets, challenges, and outcomes https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:18783 Wed 11 Apr 2018 12:33:36 AEST ]]> Barriers and challenges in performing pharmacokinetic atudies to inform sosing in the neonatal population https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:38421 Wed 08 Sep 2021 16:45:32 AEST ]]> Paediatric pharmacokinetics and drug doses https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:29326 Thu 21 Oct 2021 12:53:29 AEDT ]]> Pharmacokinetics in neonatal prescribing: evidence base, paradigms and the future https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:26443 Sat 24 Mar 2018 07:27:17 AEDT ]]> Implementation of a centralised aminoglycoside monitoring service https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:23087 Sat 24 Mar 2018 07:12:34 AEDT ]]> Development of an UHPLC-MS/MS method for remifentanil quantification in a small plasma volume https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:46877 Mon 05 Dec 2022 09:47:37 AEDT ]]>